Serum retinol level and risk of subsequent cervical cancer in cases with cervical dysplasia

Cancer Investigation

Volumn 17, Issue 4, 1999, Pages 253-258

  Nagata, Chisato ^a,f   Shimizu, Hiroyuki ^a   Higashiiwai, Hisashi ^b   Sugahara, Nobuyuki ^b   Morita, Norikazu ^c   Komatsu, Shoko ^d   Hisamichi, Shigeru ^e  

^a GIFU UNIVERSITY   (Japan)

^b MIYAGI CANCER CENTER   (Japan)

^c FUKUOKA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d SENDAI NATIONAL COLLEGE OF TECHNOLOGY   (Japan)

^e TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^f GIFU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Cervical cancer; Cervical dysplasia; Follow up; Serum retinol; Vitamin A intake

Indexed keywords

RETINOL;

ARTICLE; CANCER GROWTH; CANCER RISK; CANCER SCREENING; CARCINOGENESIS; COLPOSCOPY; DIET SUPPLEMENTATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; PAPANICOLAOU TEST; PRIORITY JOURNAL; PROGNOSIS; REGRESSION ANALYSIS; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; UTERINE CERVIX DYSPLASIA; VITAMIN BLOOD LEVEL; VITAMIN INTAKE;

EID: 0032958802     PISSN: 07357907     EISSN: None     Source Type: Journal    
DOI: 10.3109/07357909909040594     Document Type: Article

References (27)

1. Comstock GW, Bush TL, Helzlsouer K: Serum retinol, beta-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites. Am J Epidemiol 135:115-121, 1992.
2. Lupulescu A: The role of vitamin A, beta-carotene, E and C in cancer cell biology. Int J Vitamin Nutr Res 64:3-14, 1994.
3. Bernstein A, Harris B: The relationship of dietary and serum vitamin A to the occurrence of cervical intraepitherial neoplasia in sexually active women. Am J Obstet Gynecol 148:309-312, 1986.
4. Harris RWC, Forman D, Doll R, et al: Cancer of the cervix uteri and vitamin A. Br J Cancer 53:653-659, 1986.
5. Brock KE, Mock GBP, Maclennan R, et al: Nutrients in diet and plasma and risk of in situ cervical cancer. J Natl Cancer Inst 80: 580-585, 1988.
6. Palan PR, Romney SL, Nikham M, et al: Decreased plasma beta-carotene levels in women with uterine cervical dysplasias and cancer. J Natl Cancer Inst 80:454-455, 1988.
7. Basu J, Palan PR, Vermund SH, et al: Plasma ascorbic acid and beta-carotene levels in women evaluated for HPV infection, smoking, and cervix dysplasia. Cancer Detect Prev 15:165-170, 1991.
8. Butterworth CE, Hatch KD, Macaluso M, et al: Folate deficiency and cervical dysplasia. JAMA 267:528-533, 1992.
9. Batieha AW, Armenian HK, Norkus EP, et al: Serum micronutrients and the subsequent risk of cervical cancer in a population-based nested case-control study. Cancer Epidemiol Biomarkers Prev 2:335-339, 1993.
10. Shimizu H, Nagata C, Komatsu S, et al: Decreased serum retinol levels in women with cervical dysplasia. Br J Cancer 73:1600-1604, 1996.
11. Miller KW, Yang CS: An isocratic high-performance liquid chromatography method for the simultaneous analysis of plasma retinol, α-tocophenol, and various carotenoids. Ann Biochem 145: 21-26, 1985.
12. Kalbfleisch JD, Prentice R: The Statistical Analysis of Failure Time Data. New York, John Wiley and Sons, 1980, pp. 70-142.
13. Teshima K: Biological nature of dysplasia of the uterine cervix with a follow-up study. Acta Obstet Gynecol Jpn 31:727-735, 1979 [in Japanese].
14. Kiviat NB, Critchlow CW, Kurman RJ: Reassessment of the morphological continuum of cervical intraepithelial lesions: does it reflect different stage in the progression to cervical carcinoma? In: The Epidemiology of Human Papillomavirus and Cervical Cancer, edited by N Nunoz, FX Bosch, KV Shah, A Meheus, Lyon, IRAC, 1992, pp. 59-66.
15. Sporn MB, Roberts AB: Role of retinoids in differentiation and carcinogenesis. Cancer Res 43:3034-3040, 1983.
16. Lippman SM, Kavanagh JJ, Paredes-Espinoza M, et al: 13-cis-Retinoic acid plus interferon alpha-2a: highly active systemic therapy for squamous cell carcinoma of the cervix. J Natl Cancer Inst 84:241-245, 1992.
17. Meyskens FL, Surwit E, Moon TE, et al: Enhancement of regression of cervical intraepithelial neoplasia II (moderate dysplasia) with topically applied all-trans-retinoic acid: a randomized trial. J Natl Cancer Inst 86:539-543, 1994.
18. Mayne ST, Graham S, Zheng T: Dietary retinol: prevention or promotion of carcinogenesis in humans? Cancer Causes Control 2:443-450, 1991.
19. Romney SL, Palan PR, Duttagupta C, et al: Retinoids and the prevention of cervical dysplasias. Am J Obstet Gynecol 141:890-894, 1981.
20. Wylie-Rosett JA, Romney SL, Slagle S, et al: Influence of vitamin A on cervical dysplasia and carcinoma in situ. Nutr Cancer 6:49-57, 1984.
21. Potishman N, Herrero R, Brinton LA, et al: A case-control study of nutrient status and invasive cervical cancer. II. Serological indicators. Am J Epidemiol 134:1347-1355, 1991.
22. Liu T, Soong S, Wilson NP, et al: A case control study of nutritional factors and cervical dysplasia. Cancer Epidemiol Biomarkers Prev 2:525-530, 1993.
23. Creek KE, Jenkins GR, Khan MA, et al: Retinoic acid suppresses human keratinocytes and inhibits the expression of the HPV 16 oncogenes. Adv Exp Med Biol 354:19-35, 1994.
24. Ito Y, Shima Y, Ochiai J, et al: Effects of the consumption of cigarettes, alcohol and foods on serum concentration of carotenoids, retinol, and tocopherols in healthy inhabitants living in a rural area of Hokkaido. Jpn J Hygiene 46:874-888, 1991.
25. Hebert JR, Hurley TG, Hsieh J, et al: Determinants of plasma vitamins and lipids: the working well study. Am J Epidemiol 140: 132-147, 1994.
26. Shimizu H: The Basic Report on Takayama Study. Gifu, Japan, Department of Gifu University School of Medicine, 1996.
27. Nagata C, Matsushita Y, Inaba S, et al: Unapproved use of high-dose combined pills in Japan: a community study on prevalence and health characteristics of the users. Prev Med 26:565-569, 1997.